Comments

Nurix Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Nurix Therapeutics (NRIX) operate in?

Nurix Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

NRIXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Nurix Therapeutics (NRIX) Forecast

News Earnings Nurix Therapeutics (NRIX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Nurix Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:NRIX | Benzinga

Explore Nurix Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for NRIX.

Open	$10.17
Close	-
Volume / Avg.	55.09K / 822.69K
Day Range	$9.78 - $10.52
52 Wk Range	10.21 - 29.56
Market Cap	$760.45M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	26
Short Interest	18.76%
Days to Cover	14.15

Recent News

Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500

The Ark Innovation and Ark Genomic ETFs turn ten years old. A look at the annual returns and current top holdings.

Chris Katje

Wells Fargo To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Monday

Avi Kapoor

Boeing, Nurix Therapeutics And 3 Stocks To Watch Heading Into Monday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Dec 24

Jan

Feb

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$10.17
Close	-
Volume / Avg.	55.09K / 822.69K
Day Range	$9.78 - $10.52
52 Wk Range	10.21 - 29.56
Market Cap	$760.45M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	26
Short Interest	18.76%
Days to Cover	14.15

About Nurix Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and comm...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Nurix Therapeutics (NRIX) stock?

You can purchase shares of Nurix Therapeutics (NASDAQ:NRIX) through any online brokerage.

View our list of the best stock brokerages

Who are Nurix Therapeutics (NRIX) competitors?

Other companies in Nurix Therapeutics’s space includes: 89bio (NASDAQ:ETNB), Gyre Therapeutics (NASDAQ:GYRE), Syndax Pharmaceuticals (NASDAQ:SNDX), Replimune Group (NASDAQ:REPL) and Prothena Corp (NASDAQ:PRTA).

What is the forecast, or price target, for Nurix Therapeutics (NRIX) stock?

Nurix Therapeutics has a consensus price target of $30.11.

What is the current price for Nurix Therapeutics (NRIX)?

The stock price for Nurix Therapeutics (NASDAQ: NRIX) is $9.975 last updated April 4, 2025 at 9:58 AM EDT.

Does Nurix Therapeutics (NRIX) pay a dividend?

There are no upcoming dividends for Nurix Therapeutics.

When is Nurix Therapeutics (NASDAQ:NRIX) reporting earnings?

Nurix Therapeutics’s Q1 earnings are confirmed for Monday, April 21, 2025.

Is Nurix Therapeutics (NRIX) going to split?

There is no upcoming split for Nurix Therapeutics.

What sector and industry does Nurix Therapeutics (NRIX) operate in?

Nurix Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.